Descripción

Publisher's jurisdictional claims note accompanies this randomized controlled trial on anti-inflammatory diet in ulcerative colitis published in Nutrients.

Figure 5

Source Paper

Anti-Inflammatory Diet Prevents Subclinical Colonic Inflammation and Alters Metabolomic Profile of Ulcerative Colitis Patients in Clinical Remission.

Nutrients (2022)

PMID: 36014800

DOI: 10.3390/nu14163294

Cite This Figure

![Figure 5: Publisher's jurisdictional claims note accompanies this randomized controlled trial on anti-inflammatory diet in ulcerative colitis published in Nutrients.]()

> Source: Ammar Hassanzadeh Keshteli et al. "Anti-Inflammatory Diet Prevents Subclinical Colonic Inflammation and Alters Meta." *Nutrients*, 2022. PMID: [36014800](https://pubmed.ncbi.nlm.nih.gov/36014800/)

<figure>
  <img src="" alt="Publisher's jurisdictional claims note accompanies this randomized controlled trial on anti-inflammatory diet in ulcerative colitis published in Nutrients." />
  <figcaption>Figure 5. Publisher's jurisdictional claims note accompanies this randomized controlled trial on anti-inflammatory diet in ulcerative colitis published in Nutrients.<br>  Source: Ammar Hassanzadeh Keshteli et al. "Anti-Inflammatory Diet Prevents Subclinical Colonic Inflammation and Alters Meta." <em>Nutrients</em>, 2022. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/36014800/">36014800</a></figcaption>
</figure>

Evidencia relacionada

Omega-3 Fatty Acids (EPA/DHA) para Ulcerative Colitis (UC)

Calificación C · 8 estudios